AGGRESSIVE MATURE B-CELL NON-HODGKIN LYMPHOMA NOT OTHERWISE SPECIFIED

Clinical trials for AGGRESSIVE MATURE B-CELL NON-HODGKIN LYMPHOMA NOT OTHERWISE SPECIFIED explained in plain language.

Never miss a new study

Get alerted when new AGGRESSIVE MATURE B-CELL NON-HODGKIN LYMPHOMA NOT OTHERWISE SPECIFIED trials appear

Sign up with your email to follow new studies for AGGRESSIVE MATURE B-CELL NON-HODGKIN LYMPHOMA NOT OTHERWISE SPECIFIED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New combo therapy aims to beat childhood lymphoma

Disease control Recruiting now

This study is testing whether adding the drug rituximab early and intensively to a strong chemotherapy regimen can improve outcomes for children and teens with aggressive B-cell non-Hodgkin lymphoma. About 87 participants will receive the combination therapy. The goal is to see i…

Matched conditions: AGGRESSIVE MATURE B-CELL NON-HODGKIN LYMPHOMA NOT OTHERWISE SPECIFIED

Phase: PHASE2, PHASE3 • Sponsor: Children's Cancer Group, China • Aim: Disease control

Last updated Jun 27, 2026 13:02 UTC

AGGRESSIVE MATURE B-CELL NON-HODGKIN LYMPHOMA NOT OTHERWISE SPECIFIED

Get alerted when new AGGRESSIVE MATURE B-CELL NON-HODGKIN LYMPHOMA NOT OTHERWISE SPECIFIED trials appear

New combo therapy aims to beat childhood lymphoma